Latest Breaking News On - Wayne chu - Page 1 : vimarsana.com

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Roche-biontech
Chris-ogden
Piper-sandler
Sean-mccarthy
Amgen-tarlatamab
Joe-catanzaro
Peter-lawson
Wayne-chu
Zhen-su
Cytomx-therapeutics-inc
Nasdaq
Bristol-myers-squibb

CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)

CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Wayne-chu
Chris-ogden
Sean-mccarthy
Teri-dahlman
Stephanie-ascher
Nasdaq
Amgen
Redhouse-communications
Linkedin
Merck-sharp-dohme

CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA (pembrolizumab)

CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA (pembrolizumab)
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Canada
Wayne-chu
Sean-mccarthy
Cytomx-therapeutics-inc
Nasdaq

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated ...

SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced the first patient

United-states
Stephanie-ascher
Chris-ogden
Wayne-chu
Nasdaq
Linkedin
Bristol-myers-squibb
Cytomx-therapeutics-inc
Twitter
Amgen
Annual-report
Cytomx-therapeutics

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Sean-mccarthy
Chris-ogden
Wayne-chu
Relationsstephanie-ascher
Twitter
Cytomx-therapeutics-inc
Linkedin
Amgen
Bristol-myers-squibb
Nasdaq
Drug-administration

CytomX Therapeutics (CTMX) Announces FDA Clearance of IND Applications for CX-2051

CytomX Therapeutics (CTMX) Announces FDA Clearance of IND Applications for CX-2051
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sean-mccarthy
Wayne-chu
Nasdaq
Drug-administration
Cytomx-therapeutics-inc
Cytomx-therapeutics
Investigational-new-drug

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® ...

- Initiation of CX-2051 Phase 1 clinical study in EpCAM positive tumors including colorectal cancer anticipated in 1H 2024 -

United-states
Wayne-chu
Chris-ogden
Sean-mccarthy
Stephanie-ascher
Nasdaq
Drug-administration
Twitter
Bristol-myers-squibb
Amgen
Cytomx-therapeutics-inc
Linkedin

CytomX Therapeutics Outlines 2024 Company Priorities and Milestones

- CX-904 initial Phase 1a dose escalation data anticipated in the 2nd half of 2024 - - IND application filed for conditionally activated EpCAM-directed ADC with Phase 1 initiation in EpCAM.

United-states
Chris-ogden
Sean-mccarthy
Stephanie-ascher
Wayne-chu
Linkedin
Globenewswire-inc
Cytomx-therapeutics-inc
Nasdaq
Amgen
Twitter
Development-partnerships

CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Yu-waye-wayne-chu
Sean-mccarthy
Relationsstephanie-ascher
Bristol-myers-squibb-anti
Sutro-biopharma
Chris-ogden
Coherus-biosciences
Linkedin
Nasdaq
Twitter
Amgen

CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Stephanie-ascher
Sutro-biopharma
Yu-waye-wayne-chu
Sean-mccarthy
Chris-ogden
Coherus-biosciences
Bristol-myers-squibb-anti
Cytomx-therapeutics-inc
Biotest-pharmaceuticals
Nabi-biopharmaceuticals
Nasdaq